Table 3.
Demographic and clinical data of the patient’s subgroups, distributed based on the concurrency of subjective neurological symptoms.
| Demographic and Clinical Data | 0 sNS (n = 9) |
1–2 sNS (n = 26) |
≥3 sNS (n = 68) |
p Value | |
|---|---|---|---|---|---|
| Sex (M, F) | 5, 4 | 19, 7 | 35, 33 | ns | |
| Age (Mean ± SD) | 55.56 ± 12.48 | 55.61 ± 13.84 | 54.41 ± 15.35 | ns | |
| Temperature (Mean ± SD) | 36.3 ± 0.41 | 36.26 ± 0.45 | 36.31 ± 0.46 | ns | |
| Inflammatory serum markers | |||||
| WBC (x109/L) (Mean ± SD) | 6.79 ± 4.12 | 9.98 ± 7.57 | 8.32 ± 6.65 | ns | |
| Neutrophil, count (Mean ± SD) | 4.88 ± 4.5 | 7.75 ± 7.69 | 5.44 ± 4.33 | ns | |
| Lymphocyte, count (Mean ± SD) | 1.37 ± 0.71 | 1.55 ± 0.87 | 2.36 ± 5.21 | ns | |
| Neutrophil, %WB (Mean ± SD) | 0.64 ± 0.16 | 0.68 ± 0.18 | 0.65 ± 0.2 | ns | |
| Lymphocyte, %WB (Mean ± SD) | 0.26 ± 0.14 | 0.22 ± 0.15 | 0.24 ± 0.17 | ns | |
| CRP (Mean ± SD) | 14.34 ± 15.73 | 12.13 ± 21.38 | 23.19 ± 39.32 | ns | |
| sNS | n (%) | n (%) | n (%) | ||
| in order of frequency | NA | Sleep Impairment 11 (42.31) | Dysgeusia 46 (67.65) | NA | |
| Daytime Sleepiness 7 (26.92) | Sleep Impairment 40 (58.82) | ||||
| Headache 4 (15.38) | Hyposmia 38 (55.88) | ||||
| Depression 4 (15.38) | Headache 37 (54.41) | ||||
| Anxiety 4 (15.38) | Depression 35 (51.47) | ||||
| Fatigue 4 (15.38) | Anxiety 30 (44.11) | ||||
| Muscle Ache 3 (11.54) | Fatigue 29 (42.65) | ||||
| Dizziness 2 (7.69) | Daytime Sleepiness 27 (39.70) | ||||
| Hyposmia 2 (7.69) | Dizziness 24 (35.29) | ||||
| Dysgeusia 1 (3.85) | Muscle Ache 23 (33.82) | ||||
| Confusion 1 (3.85) | Confusion 22 (32.35) | ||||
| Numbness/Paresthesia 0 (0) | Numbness/Paresthesia 6 (8.82) | ||||
| Auditory Dysfunction 0 (0) | Auditory Dysfunction 2 (2.94) | ||||
List of abbreviations: n, Number; SD, Standard Deviation; M, Male patients; F, Female patients; sNS, Subjective Neurological Symptoms; WBC, white blood cells; CRP, C-reactive protein; ns, Not Significant; NA, not admitted.